Regulation of Aurora-B localization by the CPC proteins
To allow timely CPC localization, one or multiple CPC subunits should recognize a docking site (i.e., receptor) on chromosome arms, centromere, or central spindle. Because of the molecular differences between these structures (e.g., centromeric chromatin versus microtubules on the central spindle), it is likely that different receptors exist on these structures and that different CPC members are involved in the specifi c targeting of Aurora-B. The mechanism by which the CPC is targeted to the chromosome arms in unclear, but a plausible possibility would be via interaction with HP-1, as INCENP has been described to interact with this chromatin-associated protein (Ainsztein et al., 1998) . HP-1 displacement from chromosome arms is mediated by Aurora-B (Fischle et al., 2005; Hirota et al., 2005) , which could explain the transient localization of the CPC at chromosome arms during prometaphase. Also, the CPC receptors at the centromeres are unknown, but there are clues to the mechanisms by which the CPC interacts with its centromeric receptors (Fig. 2) . INCENP-deletion studies identifi ed an NH 2 -terminal domain needed for centromere localization of the CPC (Ainsztein et al., 1998) . Survivin interacts with INCENP via this domain, and replacement of this domain with Survivin suffi ces for targeting a functional CPC to the centromeres . When Survivin is linked covalently to INCENP, a functional CPC can be targeted, albeit less effi ciently, to the centromeres and central spindle in the absence of Borealin . Thus, Borealin appears to play only a minor role in centromere targeting when Survivin and INCENP are forced into a complex. However, Borealin is essential for centromere localization of the endogenous proteins, suggesting it plays a major role in promoting interaction between Survivin and INCENP. Indeed, depletion of Borealin disrupts the interaction between exogenously expressed Survivin and INCENP . Similarly, effi cient in vitro interaction between C. elegans Survivin (BIR [baculovirus IAP repeat] 1) and INCENP (ICP-1) depends on the Borealin orthologue CSC-1 (Romano et al., 2003) . Interestingly, recent data showed that Borealin also interacts with the NH 2 terminus of INCENP and that Borealin can interact with double-stranded DNA in vitro (Klein et al., 2006) , suggesting that, in addition to facilitating the Survivin-INCENP interaction, the contribution of Borealin to centromere targeting is mediated via direct interaction with chromatin (Klein et al., 2006) . Collectively, this allows for a model in which Survivin and Borealin cooperatively mediate centromere targeting of the CPC through multiple docking sites, including the chromatin itself. By interacting with the NH 2 terminus of INCENP, these proteins can then recruit INCENP and Aurora-B to centromeres. Because Survivin and Borealin can oligomerize in vitro (Chantalat et al., 2000; Muchmore et al., 2000; Verdecia et al., 2000; Gassmann et al., 2004) , it is possible that a heterooligomer of Borealin and Survivin assembled on the NH 2 terminus of INCENP forms the centromere binding interface of the CPC. Within Survivin, the BIR domain is the most likely domain to interact with putative CPC receptors at the centromere, as disruption of this domain impaired CPC centromere function (but not Borealin interaction; Lens et al., 2006) . Interestingly, Bir1p, the S. cerevisiae Survivin ortho logue, interacts with Ndc10, a subunit of the centromere binding factor-3 complex (Yoon and Carbon, 1999) , making this protein a good candidate for a CPC centromere receptor. However, a mammalian orthologue of Ndc10 has not been identifi ed. Clearly, identifying Survivin (BIR domain) and Borealin interactors is necessary to further elucidate the mechanisms of CPC centromere targeting.
Most of our knowledge regarding CPC centromere targeting is based on immunofl uorescence data in fi xed cells. However, it is clear that association of the CPC to centromeres is highly dynamic. For example, Survivin localizes dynamically to the centromere (Beardmore et al., 2004) . Inhibition of Aurora-B or depolymerization of microtubules greatly reduces Survivin turnover at centromeres (Beardmore et al., 2004) , suggesting that CPC localization and microtubule attachment are linked during prometaphase/metaphase. Indeed, recent evidence showed that proper dynamics of Survivin (and presumably the entire CPC) at the centromeres is essential for proper chromosome alignment. Vong et al. (2005) identifi ed ubiquitination as a posttranslational modifi cation required for proper targeting and dynamics of Survivin at centromeres. Interference with this process, by removing either a deubiquitinating enzyme (hFAM) or a ubiquitin binding protein (Ufd1) impaired localization and turnover of Survivin at the centromeres and, as a consequence, disturbed chromosome alignment (Vong et al., 2005) . Moreover, Survivin is also an Aurora-B substrate, and mimicking constitutive phosphorylation impairs centromere localization (Wheatley et al., 2004 ). It will be interesting to see whether these modifi cations are interdependent and/or infl uence each other and how posttranslational modifi cations on Survivin can infl uence the function of the entire CPC.
From centromere to central spindle
To function during cytokinesis, Aurora-B needs to translocate from the centromeres to the central spindle at the metaphaseanaphase transition. In S. cerevisiae, this translocation is negatively regulated by cyclin B/Cdk1-dependent phosphorylation of INCENP. Dephosphorylation of residues within the coiledcoil domain of INCENP by Cdc14 triggers translocation of the CPC to the central spindle (Pereira and Schiebel, 2003) . However, a recent phosphoproteomics analysis failed to identify phoshosites in the coiled-coil domain of human INCENP. Yet, multiple putative cyclin B/Cdk1 phosphosites were identifi ed in a region in INCENP previously shown to interact with HP-1 (Ainsztein et al., 1998; Nousiainen et al., 2006) . Together with the observation that expression of a nondegradable cyclin B mutant prevented spindle transfer of Aurora-B during anaphase in human cells (Murata-Hori et al., 2002) , this suggests that phospho-dependent regulation of CPC spindle transfer is conserved but that different domains in INCENP might be involved. Besides the phosphosites found within the HP-1 binding domain, several additional residues in INCENP were found to be phosphorylated during mitosis, suggesting complex phosphodependent regulation of the human CPC (Nousiainen et al., 2006) . Relocalization of the CPC from centromeres to the central spindle at the metaphase-anaphase transition also requires dynamic microtubules, as treatment of anaphase cells with the microtubule-stabilizing drug taxol impaired central spindle targeting (Wheatley et al., 2001) . INCENP interacts directly with polymerized microtubules via its coiled-coil domain (Mackay et al., 1993) . Additionally, a small domain in the NH 2 terminus of INCENP interacts with β-tubulin and is essential for effi cient spindle localization of the CPC (Ainsztein et al., 1998; Wheatley et al., 2001) . Survivin can also interact in vitro with polymerized microtubules, and mutation of the coiled-coil domain in Survivin impaired this interaction (Li et al., 1998) , suggesting a dual interaction of the CPC with microtubules (i.e., via INCENP and Survivin). However, it is unclear whether this interaction is crucial for proper CPC localization during anaphase. Besides microtubules, central spindle localization of the CPC also depends on Mklp2, a mitotic kinesin. In human cells depleted of Mklp2, the CPC fails to relocalize to the central spindle during anaphase (Gruneberg et al., 2004) . Aurora-B directly interacts with Mklp2 in human cells (Gruneberg et al., 2004) , and similarly, C. elegans Aurora-B functionally interacts with the related kinesin Zen-4 (Severson et al., 2000) . In this case, Aurora-B itself targets the CPC to the central spindle by interacting with Mklp2. Additionally, Mklp2 interacts with and is required for central spindle localization of human Cdc14a, a homologue of S. cerevisiae Cdc14. Altogether, relocalization of the CPC to the central spindle depends on the orchestrated actions of at least spindle microtubules, Mklp2, and Cdc14 (Fig. 2) .
Is centromere localization a prerequisite for central spindle localization? Initial experiments in which disruption of centromeric localization also impaired anaphase spindle transfer indicated that it might be (Ainsztein et al., 1998) . However, Drosophila melanogaster mutants undergoing meiosis without chromosomes can execute cytokinesis and concomitantly localize Aurora-B to the central spindle (Bucciarelli et al., 2003) . Additionally, recent experiments revealed that the COOHterminal region of Survivin (the region containing the coiledcoil domain that binds microtubules in vitro [Li et al., 1998 ]) is suffi cient to direct a functional CPC to the central spindle without prior centromere concentration . It will be interesting to investigate whether this domain in Survivin interacts in vivo with one of the known central spindle CPC receptors or with as-yet-unidentifi ed central spindle receptors. Taken as a whole, it seems that, although in normal cells centromeric and central spindle localization are tightly linked, they can be uncoupled and involve different targeting mechanisms.
Activation of Aurora-B and CPC phosphorylation
In vitro experiments have demonstrated that INCENP is critically needed to activate Aurora-B. INCENP interacts with Aurora-B via its conserved COOH-terminal IN-box, and incubation of this domain with Aurora-B causes an increase in kinase activity (Kang et al., 2001; Bolton et al., 2002) . Addition of Borealin does not activate Aurora-B in vitro (Gassmann et al., 2004) , whereas confl icting data exist regarding the ability of Survivin to activate Aurora-B. In Xenopus laevis extracts, Survivin is needed for full Aurora-B activity (Bolton et al., 2002) , but in vitro experiments with human proteins did not reveal a role for Survivin in activating Aurora-B, whereas INCENP could activate Aurora-B in this in vitro setup, suggesting that INCENP is the major Aurora-B activator in human cells (Honda et al., 2003) . Alternatively, in vivo regulatory mechanisms might exist (e.g., additional proteins and/or posttranslational modifi cations) that are needed for additional Survivin-dependent activation of Aurora-B.
INCENP, Survivin, and Borealin are subject to phosphorylation by Aurora-B (Fig. 1) . INCENP phosphorylation at a TSS motif close to the IN-box induces a conformational change in Aurora-B, causing full activation of Aurora-B (Sessa et al., 2005) . This phosphorylation is essential for in vitro (Honda et al., 2003; Sessa et al., 2005) and in vivo (unpublished data) functionality of Aurora-B. Survivin is phosphorylated on threonine-117 by Aurora-B in vitro (Wheatley et al., 2004) , and this phosphorylation is involved in regulating localization (see Regulation of Aurora-B localization by the CPC proteins). The COOH terminus of Borealin is phosphorylated by Aurora-B, but the functionality of this phosphorylation is unknown (Gassmann et al., 2004) . Further research regarding these phosphorylations in CPC function (e.g., on localization and dynamics) will be necessary to deepen our understanding of CPC regulation. Additionally, it will also be interesting to explore whether INCENP, Survivin, and Borealin also infl uence substrate specifi city and recognition of Aurora-B.
Concluding remarks
Aurora-B kinase activity is essential for faithful chromosome segregation and execution of cytokinesis. To fulfi ll these critical functions, the kinase needs to be in its active conformation at the right place at the right time. It is clear that activity and localization of Aurora-B is tightly controlled by its interaction partners INCENP, Survivin, and Borealin. Because Aurora-B is targeted to different structures during prometaphase/metaphase and anaphase (i.e., centromeric chromatin and microtubules/ tubulin, respectively), it will be a challenge to build a complete picture of the CPC-specifi c receptors on these structures and the composition of CPC proteins that serve as ligands for these receptors. Because Aurora-B is a promising anti-cancer drug target (Keen and Taylor, 2004) , interference with these receptorligand interactions by small molecules could be an alternative therapeutic strategy for disturbing Aurora-B function.
